This observation is consistent with studies that showed that Twist2 is a potential diagnostic marker that promotes mesenchymal transition through the downregulation of E-cadherin in female patients with cervical carcinomas (11) and breast cancer (22). The gene discussed is CDH1; the disease is breast cancer.